Objective: To evaluate the association between a clustering of cardio-metabolic risk factors in parents and the development of microalbuminuria (MA) in their offspring with childhood-onset type 1 diabetes (T1D). Conclusions: Parents of young offspring with childhood-onset T1D and MA showed an abnormal metabolic profile, reflected by a calculated risk score. The finding supports the role of a familial predisposition to risk of developing diabetic nephropathy.
| INTRODUCTION
Diabetic nephropathy (DN) and cardiovascular disease (CVD) are among the most common vascular complications of type 1 diabetes (T1D), which adversely influence the long-term prognosis of people with this disease. [1] [2] [3] Several studies have shown that premature atherosclerosis represents the main cause of morbidity and mortality in patients with T1D. 1, 4 Although hard end-points, such as stroke and ischemic heart disease, are uncommon in children and adolescents with T1D, early subclinical structural and functional vascular abnormalities are often found in this age group. 5, 6 Risk for CVD in patients with T1D is strongly associated with the presence of renal disease, as supported by the higher CVD morbidity and mortality in people with increased albumin excretion rates. 7, 8 In addition, cardio-metabolic risk factors, such as increased blood pressure and lipid levels, visceral adiposity, insulin resistance, impaired glucose tolerance, and their combination, known as metabolic syndrome, are strong predictors for CVD risk in the general † They are joint first authors.
population and in people with T1D. [9] [10] [11] Based on these data, the investigation of specific cardio-metabolic risk factors and their clustering within families has become an appealing research area over the last years. A recent study on a large population of 12-year-old children and their parents showed that a family history of CVD had a key impact on the cardio-metabolic profile of the offspring, thus highlighting the importance of identifying CVD risk factors within families for preventive strategies. 9 In adults with T1D a family history of hypertension or insulin resistance/type 2 diabetes has been associated with risk of DN in the offspring. [12] [13] [14] [15] Some studies have also highlighted that a clustering of familial cardio-metabolic risk factors could have a stronger effect than individual factors on risk of DN. 14 Up to now, the association between familial cardio-metabolic risk factors and/or their clustering and risk of early stages of DN, such as microalbuminuria (MA), has not been fully assessed in families of young people with childhood-onset T1D. Previously, our group was able to replicate some of the findings reported in adults with T1D in young cohorts of children and adolescents with T1D, where parental blood pressure emerged to have an independent effect on MA risk in the offspring. 16, 17 A similar association between parental history of hypertension and MA in the offspring was reported in other 2 previous studies. 18, 19 In contrast, we were not able to show any effect of parental lipid levels on the risk of MA in the offspring. 20 The aim of this study was to investigate the association between an aggregation of cardio-metabolic risk factors in parents of young people with T1D and the occurrence of MA during adolescence in the offspring.
| METHODS

| Study design
This was a nested case-control study within the Nephropathy Family Study (NFS) and Oxford Regional Prospective Study (ORPS) cohorts, 21, 22 where parents of probands with childhood-onset T1D
were assessed. Cases were parents of T1D probands who had developed MA during childhood and adolescence, whereas controls were parents of probands who had not developed MA after a long follow-up.
Once potential probands with MA were identified, 2 control probands without MA were selected within the same ORPS/NFS cohorts and were matched for age, sex, and duration of diabetes with the probands with MA. Parents of both groups were approached by sending invitation letters together with information leaflets about the study.
After the parents agreed to take part in the study and after they signed the informed consent they underwent a clinical, biochemical, and cardiovascular imaging assessment, which were performed during 2 study visits. The study protocol was approved by the Ethics Committee in
Cambridge, UK. The study was carried out in conformation with the spirit and the letter of the Declaration of Helsinki and in accordance with the guidance in Good Clinical Practice. Written signed informed consent was obtained from the study participants before the beginning of the study and any study assessment. 
| Study visits
| Laboratory methods
Blood glucose was measured using an adaption of the hexokinase-glucose-6-phosphate dehydrogenase method on a Siemens Dimension analysers (RxL and EXL).
Plasma insulin concentrations were measured using a DAKO ELISA (DAKO Ltd., Denmark House, Ely, Cambs, UK) according to the manufacturer's instructions.
Lipids: measurements of total cholesterol, high-density lipoprotein (HDL)-cholesterol and triglycerides were performed enzymatically on a Dimension RXL system (Dade Behring) using reagents and calibrants supplied by the manufacturer.
hsCRP: was measured in plasma samples by laser immunonephelometry (Dade Behring).
ADMA: was measured by stable isotope dilution electrospray tandem mass spectrometry, as previously described.
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HbA1c: was measured centrally on a TOSOH G7 analyzer, using high-performance liquid chromatography and absorbance change detection and Diabetes Control and Complications Trial aligned methods.
Urinary albumin and creatinine: were measured centrally as previously described. The effective radiation dose was 0.1 μSievert. The scan yielded measures of whole-body fat and fat-free mass (FFM) and therefore percent whole-body fat mass. All DXA scans were performed in compliance with local IR(ME)R Employer's Procedures.
| Calculations
Cardio-metabolic risk score: A continuous clustered cardio-metabolic risk score (z-score) was computed. This score represents a summary variable for components of metabolic syndrome, which gives a standardized estimate and has been used in several studies.
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The cardio-metabolic risk score was calculated based on previous studies and included the average value of age and sexstandardized measures (z-scores) for 6 outcomes: measures of central obesity (waist circumference), dyslipidemia (triglycerides and HDL-cholesterol), hypertension (systolic and diastolic blood pressure), and glucose metabolism (fasting glucose and insulin). 
| Study endpoints
The primary study endpoint was defined as the difference in the continuous cardio-metabolic risk score between parents of MA positive and MA negative offspring.
The secondary endpoints were defined as differences between the 2 study groups in (1) 
| Statistical methods
The cardio-metabolic risk score and the individual cardio-metabolic parameters and body composition measurements between parents of MA positive and MA negative offspring were compared using a 2 sample unpaired t-test (2 tailed). In case of not normally distributed variables, a log base 10 transformation was applied before testing.
Analysis of covariance was used when adjustments for potential confounding factors where required. both parents agreed to take part in the study, whereas for the remaining 31 only 1 parent agreed to take part in the study (22 mothers and 9 fathers) ( Table 1 ). The general characteristics of the offspring are reported in Table 2 .
3.1 | Cardio-metabolic risk score in the parents: MA positive vs MA negative group
Parents of MA positive offspring were similar in age, height, weight and BMI compared with parents of MA negative offspring (Table 3) . (Table 3) .
| Cardiovascular imaging in parents of MA positive vs MA negative offspring
There were no statistically significant differences in the circulating cardiovascular markers ADMA and hsCRP between parents of MA positive and MA negative offspring. Similarly, urinary ACR was similar between the 2 groups (Table 3) .
No significant differences were found in the cardiovascular measurements including cIMT, FMD and PWV, before and after adjusting for potential confounders such as age and sex (Table 4 ).
| Body composition in parents of MA positive vs MA negative offspring
No significant difference in total fat and lean mass, gynoid, android, limbs and trunk fat mass were found between parents of MA positive and MA negative children (Table 4) . 
| DISCUSSION
In the present nested case-control study within the ORPS/NFS cohorts, a clustering of parental cardio-metabolic risk factors, expressed as a cardio-metabolic risk score, was assessed in relation to the development of MA in the offspring. The main study finding was that the cardio-metabolic risk score was higher in parents of offspring who developed MA during adolescence compared to parents of those who did not develop this complication.
Although glycemic control is an important risk factor for renal and other vascular complications of T1D, it does not entirely explain risk, particularly during puberty, when hormonal and metabolic changes, together with lifestyle, environmental exposures and genetic/familial factors may also significantly contribute to the overall complication risk. 5, 6 Previously, our group and others have shown that during adolescence, in addition to poor glycemic control, factors associated with increased albumin excretion and presence of MA are high blood pressure, dyslipidemia, inflammatory markers, hyperfiltration. 5, 6 Inherited cardio-metabolic risk factors, such as lipid, blood pressure, insulin resistance, obesity, have also been suggested as potential contributing factors to the overall risk of developing MA and DN. [12] [13] [14] [15] [16] One way for exploring the role of inherited factors is assessing them within families. Previous family studies in adults with T1D have reported an association between parental CVD risk factors, such as hypertension, insulin resistance and type 2 diabetes, as well as their clustering, and presence of nephropathy in the offspring. [12] [13] [14] [15] Limited data are available for young people with childhood-onset T1D. [16] [17] [18] [19] [20] In 2 previous studies, we showed an independent effect of parental blood pressure, assessed by 24-hour ambulatory blood pressure monitoring, on urinary albumin excretion in young offspring with T1D. 16, 17 In contrast, parental lipid levels, although being an independent predictor of the same trait in the offspring, did not emerge to be a contributing factor for variations in albumin excretion in offspring from the same cohorts. 17, 20 In the present study we aimed to extend these findings and assess the effect of a clustering of cardio-metabolic risk factors on MA risk. Interestingly, the standardized cardio-metabolic risk score we used in the study emerged to be higher in parents of offspring with MA. This association could be explained by a similar genetic background influencing cardio-metabolic profiles in the parents and risk of MA in the offspring. An alternative explanation might be the effect of sharing lifestyle behaviors between parents and offspring, which might be a key target for preventive strategies, or the effect of shared sociodemographic influences.
Over the last years, the use of a continuous cardio-metabolic risk score has been suggested and proved to be a valid tool for epidemiological and clinical studies. [26] [27] [28] [29] In particular, a continuous cardiometabolic risk score can offer some advantages compared to the use of dichotomous variables, such as presence or absence of metabolic syndrome. One important advantage is a higher statistical power. In addition, a continuous score has been shown to better reflect the fact that cardiovascular risk is a progressive function of several risk factors, thus removing problems related to the application of arbitrary cutoffs. 29 In our study the use of the cardio-metabolic score also allowed us to make adjustments for specific treatments, such as for hypertension/dyslipidemia or for presence of diabetes, which can be common in adult populations, and which can influence comparisons of individual data on lipids, blood pressure, glucose/insulin levels.
Most of the individual components of the cardio-metabolic risk score taken individually tended to be higher in parents of offspring with MA than in parents of offspring without this complication, but only the difference in diastolic blood pressure reached statistical significance. The latter finding confirms previous observations in young people with T1D, where parental blood pressure or a history of hypertension was one of the main familial risk factors associated risk of MA in the offspring. 12, [16] [17] [18] [19] In the present study, no significant differences were found in circulating markers of CVD such as hsCRP, ADMA or ACR. Similarly, no differences were found in direct measures of vascular structure and function. This could be due to lack of sufficient power to detect changes in these parameters, for which differences could be subtler than those seen in the cardio-metabolic risk score, and therefore might emerge only with larger sample sizes. Another potential explanation for the lack of differences in these specific CVD measures could be that they might emerge later at an older age in the parents.
Indeed, compared to previous studies assessing families of patients with T1D, parents in the present study were younger, with a mean age of around 56 years.
A major strength of the present study was that parents underwent direct assessments during the study visits, including collection of anthropometric measurements, blood samples for measuring circulating markers of CVD, direct imaging measures of vascular structure and function. In contrast, previous studies have been mainly based on collections of family history of cardiovascular events through questionnaires or direct interviews. 13, 30 One potential limitation of the study was the sample size, which was not particularly high, although a power calculation was performed and we were able to recruit a sufficient number of subjects to detect the expected differences in the primary outcome. As stated above, it could be that the power was not enough to detect subtler changes in direct measures of vascular structure and function.
Another potential study limitation is related to the fact that we were not able to recruit complete mother-father pairs for all offspring. This would have allowed a more detailed analysis of potential differences between the effects of maternal vs paternal cardio-metabolic risk factors on MA risk in the offspring. The lack of an assessment of the offspring in their early adulthood, at the time when the parents were assessed, also needs to be acknowledged. However, the main study aim was to assess whether parental cardio-metabolic risk factors were more common among young people with T1D who developed MA during pubertal years.
| CONCLUSIONS
This study showed that MA in young offspring with childhood-onset T1D was associated with an abnormal cardio-metabolic profile in the parents, mainly driven by abnormal blood pressure, thus highlighting that the familial influence on risk of developing renal complications previously described in adult patients with diabetes, exists also in young people with an early onset of T1D.
These findings underline the importance of considering familial cardio-metabolic risk factors when one is estimating the renal risk in young offspring with diabetes. In particular, the characterization of familial risk factors predisposing to the development of MA could help 1 P values are adjusted for parental age and sex.
2 Data are meanAESD.
3 PWV was also adjusted for blood pressure.
cIMT, carotid intima-media thickness, DXA, dual-energy x-ray absorptiometry; FMD: flow mediated dilatation, PWV: pulse wave velocity; VTI: velocity time integral.
in identifying patients at a higher risk of developing diabetic complications, who might require more intensive preventive and treatment strategies to prevent their development and/or slow their progression.
Future studies are required to explore whether the reported association is related to a common genetic background or might be related to shared lifestyle/sociodemographic factors, which could be targeted to reduce DN in offspring with T1D.
